Infectious Diseases And Therapy

SCIE

國際簡稱：INFECT DIS THER 參考譯名：傳染病與治療

主要研究方向：Medicine-Microbiology (medical) 非預(yù)警期刊審稿周期： 6 Weeks

《傳染病與治療》(Infectious Diseases And Therapy)是一本由Springer Healthcare出版的以Medicine-Microbiology (medical)為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
144 年發(fā)文量
4.7 IF影響因子
開放是否OA
2012 創(chuàng)刊年份
6 issues per year 出版周期
English 出版語言

Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.

[ 查看全部 ]

投稿咨詢加急咨詢

Infectious Diseases And Therapy期刊信息

ISSN：2193-8229
出版語言：English
是否OA：開放
E-ISSN：2193-6382
出版地區(qū)：ENGLAND
是否預(yù)警：否
出版商：Springer Healthcare
出版周期：6 issues per year
創(chuàng)刊時(shí)間：2012
開源占比：0.9927
Gold OA文章占比：98.50%
OA被引用占比：1
出版國人文章占比：0.04
出版撤稿占比：0
研究類文章占比：77.78%

Infectious Diseases And Therapy CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

8.6

1.351

1.311

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Infectious Diseases	Q1	61 / 344	82%
大類：Medicine 小類：Microbiology (medical)	Q1	31 / 140	78%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Infectious Diseases And Therapy中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INFECTIOUS DISEASES 傳染病學(xué)	3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INFECTIOUS DISEASES 傳染病學(xué)	3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INFECTIOUS DISEASES 傳染病學(xué)	4區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	INFECTIOUS DISEASES 傳染病學(xué)	2區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INFECTIOUS DISEASES 傳染病學(xué)	4區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	INFECTIOUS DISEASES 傳染病學(xué)	3區(qū)

Infectious Diseases And Therapy JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：INFECTIOUS DISEASES	SCIE	Q1	20 / 132	85.2%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：INFECTIOUS DISEASES	SCIE	Q1	32 / 132	76.14%

Infectious Diseases And Therapy歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Infectious Diseases And Therapy中國學(xué)者發(fā)文選摘

1、Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study
Author: Xu, Wei; Hu, Qiankun; Chen, Chong; Li, Weixia; Li, Qiang; Chen, Liang

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 487-498. DOI: 10.1007/s40121-022-00738-1
2、Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019
Author: Li, Meng; Yang, Shanshan; Yao, Hongwu; Liu, Yunxi; Du, Mingmei

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 473-485. DOI: 10.1007/s40121-022-00732-7
3、Association Between Lactate and 28-Day Mortality in Elderly Patients with Sepsis: Results from MIMIC-IV Database
Author: He, Liudang; Yang, Donghua; Ding, Qiong; Su, Yingjie; Ding, Ning

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 459-472. DOI: 10.1007/s40121-022-00736-3
4、Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19
Author: Meng, Qing; Li, Wujiao; Jiang, Hanfang; Yan, Huimin; Wang, Heping; Ye, Binjun; Zhou, Lintao; Chen, Yunsheng

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 563-575. DOI: 10.1007/s40121-022-00751-4
5、The Association Between Alveolar-Arterial Oxygen Tension Difference and the Severity of COVID-19 in Patients
Author: Xie, Canbin; Deng, Jiayi; Li, Fanglin; Wu, Chenfang; Xu, Min; Yu, Bo; Wu, Guobao; Zhong, Yanjun; Tang, Da; Li, Jinxiu

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 577-587. DOI: 10.1007/s40121-022-00752-3
6、Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients
Author: Weng, Chengzhao; Xie, Rongcheng; Han, Guanjie; Yuan, Ya; Li, Shiqin; Wang, Chao; Wang, Xiaofeng; Jiang, Wei; Jiang, Libo

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 649-662. DOI: 10.1007/s40121-023-00760-x
7、Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults
Author: Chen, Guiling; Li, Nan; Dai, Xiahong; Tu, Shiyan; Shen, Zhenwei; Wu, Kaiqi; Jin, Tinghan; Wu, Jiajun; Peng, Conggao; Sheng, Guoping; Zhu, Mengfei; Tang, Lingling; Li, Lanjuan

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 663-675. DOI: 10.1007/s40121-023-00759-4
8、Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study
Author: Huang, Shuai-Wen; Li, Xi-Tang; Chen, Chen; Ning, Qin; Huang, Jia-Quan

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 3, pp. 871-890. DOI: 10.1007/s40121-023-00766-5